Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has "a great story to tell, with or without the data."
He was diagnosed years ago with a handful of autoimmune conditions, treating them with drugs like Abbvie's Humira, which he helped commercialize.
Susan Sweeney has earned a reputation for such pragmatism and attentiveness to the things that really matter.
Jim Caggiano had witnessed Provenge's birth during an earlier turn at Dendreon and couldn't understand what went wrong.
Under Duato, the leadership team for Johnson & Johnson's pharma group includes six women. "We don't just talk about it," he says.
He describes his current charge as "transforming a more creative occupation into a science."
"In Australia, we are the healthcare industry," he says.
Only one new osteoporosis drug has been approved over the last six years.
Avanir's success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion
Too often left undiscussed is that a powerful business case can be made for more frequent and focused mentorship.
With a lead role in IBM Watson's bold gambit to transform healthcare, Kathy McGroddy-Goetz ranks as one of the enterprise's most important individuals.
The motivating force behind My GI Health met initial resistance. After all, it came from a company executive who professed that his goal was to benefit all companies within that therapeutic area.
Tom McCourt says he's "a marketing guy who hopefully understands a little about drug development" even as he guided drugs like Prilosec to market.
The Medicines Company's commercial lead for infection disease care talks about its breakthrough antidote for carbapenem-resistant enterobacteriaceae.
Prior to Medicines360's arrival on the scene, there were only three IUDs on the market. The lack of competition drove prices sky-high.
David Meek has been charged with building an oncology arm that matches the company's existing strengths in hematology and immunology.
"Partnering up in complete transparency is the best possible scenario for patients"
"Gene therapy is a collection of small details. It's not a secret sauce."
Alcon ace pilots lens work with Google
Amy Clarke Luchsinger "thinks that HCPs want both digital and print. The people [she] talks with just want to be able to access information when and where they want it . . .
He didn't want to just invest in a winning horse—he wanted to help groom it
"An epidemic comes and goes. This is a trend curve. We need to bend that curve."
The Healthcare Businesswoman's Association 2015 Honorable Mentor has elevated mentoring to a prominent place.
"Some people wake up in the middle of the night worrying about business," Kevin Sayer says. But when he wakes up he can't sleep because he's so excited!
Anne Whitaker, President and CEO, Synta Pharmaceuticals
Thomas Sack, President and CEO, MRIGlobal
Adding skills diversity to Purdue's talent base is an important goal
Dennis Urbaniak, managing director, Accenture Life Sciences
Steve Cashman, Founder and CEO, HealthSpot